We are testing how well different doses of BI 764532 are tolerated by people with small cell lung cancer when combined with chemotherapy. This study aims to find the safest and most effective dose.
Health conditions and diseases that the clinical trial is designed to study and treat.
Extensive Stage Small Cell Lung Cancer (ES-SCLC) is a type of lung cancer that has spread beyond the lungs and is known for its aggressive nature. Patients may experience symptoms such as persistent cough, chest pain, shortness of breath, and weight loss.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
